{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:01:51Z","timestamp":1768784511602,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.amjcard.2015.09.029","type":"journal-article","created":{"date-parts":[[2015,10,17]],"date-time":"2015-10-17T08:17:32Z","timestamp":1445069852000},"page":"1890-1897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)"],"prefix":"10.1016","volume":"116","author":[{"given":"Michael","family":"B\u00f6hm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Borer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Komajda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Kindermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Maack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitja","family":"Lainscak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Swedberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2015.09.029_bib1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.09.029_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjmed.2010.08.017","article-title":"Trends in comorbidity, disability, and polypharmacy in heart failure","volume":"124","author":"Wong","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2015.09.029_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2013.09.070","article-title":"Frailty assessment in the cardiovascular care of older adults","volume":"63","author":"Afilalo","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.029_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1152\/physrev.1993.73.2.413","article-title":"Cardiovascular regulatory mechanisms in advanced age","volume":"73","author":"Lakatta","year":"1993","journal-title":"Physiol Rev"},{"key":"10.1016\/j.amjcard.2015.09.029_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s11606-007-0180-x","article-title":"Patients at-risk for cost-related medication nonadherence: a review of the literature","volume":"22","author":"Briesacher","year":"2007","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.amjcard.2015.09.029_bib6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jama.294.6.716","article-title":"Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance","volume":"294","author":"Boyd","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2015.09.029_bib7","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","article-title":"Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure","volume":"42","author":"Braunstein","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.029_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ejhf.23","article-title":"Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure","volume":"16","author":"B\u00f6hm","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2015.09.029_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/eurjhf\/hfp154","article-title":"Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT)","volume":"12","author":"Swedberg","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2015.09.029_bib10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2015.09.029_bib11","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"B\u00f6hm","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2015.09.029_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.110.979203","article-title":"Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community","volume":"124","author":"Lam","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.029_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2015.09.029_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00392-012-0467-8","article-title":"Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study","volume":"102","author":"B\u00f6hm","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.029_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ejhf.59","article-title":"The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT","volume":"16","author":"Voors","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2015.09.029_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2013.10.068","article-title":"Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study","volume":"170","author":"Tavazzi","year":"2013","journal-title":"Int\u00a0J Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.029_bib17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/eurjhf\/hft102","article-title":"Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study","volume":"15","author":"Tavazzi","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2015.09.029_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.amjcard.2013.10.033","article-title":"Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study)","volume":"113","author":"Borer","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.029_bib19","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.jacc.2009.08.019","article-title":"Hospitalizations after heart failure diagnosis:\u00a0a\u00a0community perspective","volume":"54","author":"Dunlay","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.029_bib20","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurjhf\/hfr116","article-title":"Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups","volume":"13","author":"Mogensen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2015.09.029_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa0808836","article-title":"Percent emphysema, airflow obstruction, and impaired left ventricular filling","volume":"362","author":"Barr","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.09.029_bib22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/archinte.166.10.1134","article-title":"Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease","volume":"166","author":"Smith","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2015.09.029_bib23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients: a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.029_bib24","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/eurheartj\/ehr255","article-title":"Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis","volume":"33","author":"Schirmer","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2015.09.029_bib25","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/ehs250","article-title":"Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke","volume":"33","author":"B\u00f6hm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2015.09.029_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/HYPERTENSIONAHA.114.04568","article-title":"Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk","volume":"65","author":"B\u00f6hm","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2015.09.029_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/joim.12333","article-title":"Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies","volume":"278","author":"B\u00f6hm","year":"2015","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.amjcard.2015.09.029_bib28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11886-012-0259-9","article-title":"The comorbidity conundrum: a focus on the role of noncardiovascular chronic conditions in the heart failure patient","volume":"14","author":"Page","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.amjcard.2015.09.029_bib29","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.162.20.2269","article-title":"Prevalence, expenditures, and complications of multiple chronic conditions in the elderly","volume":"162","author":"Wolff","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2015.09.029_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/aje\/153.3.299","article-title":"Validity of self-reported cancer history: a comparison of health interview data and cancer registry records","volume":"153","author":"Desai","year":"2001","journal-title":"Am J Epidemiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915020081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915020081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T17:06:11Z","timestamp":1567271171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914915020081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0002914915020081"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.09.029","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}